LABCORP HOLDINGS INC. Research and Development Expense
LABCORP HOLDINGS INC. (LH) reported Research and Development Expense of $3.00 million for the 3-month period ending 2010-09-30, per its 10-Q filed 2010-11-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2010-11-01
- LABCORP HOLDINGS INC. research and development expense for the quarter ending 2010-09-30 was $3.00M, a 20.00% increase year-over-year.
- LABCORP HOLDINGS INC. research and development expense for the quarter ending 2010-06-30 was $3.00M.
- LABCORP HOLDINGS INC. research and development expense for the quarter ending 2009-09-30 was $2.50M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month |
|---|---|---|---|
| 2010-09-30 | $3.00M 10-Q · filed 2010-11-01 | $6.00M derived: sum of 2 quarters · filed 2010-11-01 | $9.40M 10-Q · filed 2010-11-01 |
| 2010-06-30 | $3.00M 10-Q/A · filed 2010-08-20 | $6.40M 10-Q/A · filed 2010-08-20 | |
| 2009-09-30 | $2.50M 10-Q · filed 2010-11-01 | $2.50M 10-Q · filed 2010-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |